Copyright Reports & Markets. All rights reserved.

Global Enoxaparin Sodium Market Research Report 2021

Request for Sample of this report
Buy now

1 Enoxaparin Sodium Market Overview

  • 1.1 Product Overview and Scope of Enoxaparin Sodium
  • 1.2 Enoxaparin Sodium Segment by Type
    • 1.2.1 Global Enoxaparin Sodium Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 30 mg/0.3mL
    • 1.2.3 60 mg/0.6mL
    • 1.2.4 100 mg/1mL
    • 1.2.5 120 mg/0.8mL
    • 1.2.6 150 mg/1mL
  • 1.3 Enoxaparin Sodium Segment by Application
    • 1.3.1 Enoxaparin Sodium Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Drugs Store
  • 1.4 Global Enoxaparin Sodium Market Size Estimates and Forecasts
    • 1.4.1 Global Enoxaparin Sodium Revenue 2016-2027
    • 1.4.2 Global Enoxaparin Sodium Sales 2016-2027
    • 1.4.3 Enoxaparin Sodium Market Size by Region: 2016 Versus 2021 Versus 2027

2 Enoxaparin Sodium Market Competition by Manufacturers

  • 2.1 Global Enoxaparin Sodium Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Enoxaparin Sodium Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Enoxaparin Sodium Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Enoxaparin Sodium Manufacturing Sites, Area Served, Product Type
  • 2.5 Enoxaparin Sodium Market Competitive Situation and Trends
    • 2.5.1 Enoxaparin Sodium Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Enoxaparin Sodium Players Market Share by Revenue
    • 2.5.3 Global Enoxaparin Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Enoxaparin Sodium Retrospective Market Scenario by Region

  • 3.1 Global Enoxaparin Sodium Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Enoxaparin Sodium Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Enoxaparin Sodium Market Facts & Figures by Country
    • 3.3.1 North America Enoxaparin Sodium Sales by Country
    • 3.3.2 North America Enoxaparin Sodium Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Enoxaparin Sodium Market Facts & Figures by Country
    • 3.4.1 Europe Enoxaparin Sodium Sales by Country
    • 3.4.2 Europe Enoxaparin Sodium Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Enoxaparin Sodium Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Enoxaparin Sodium Sales by Region
    • 3.5.2 Asia Pacific Enoxaparin Sodium Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Enoxaparin Sodium Market Facts & Figures by Country
    • 3.6.1 Latin America Enoxaparin Sodium Sales by Country
    • 3.6.2 Latin America Enoxaparin Sodium Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Enoxaparin Sodium Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Enoxaparin Sodium Sales by Country
    • 3.7.2 Middle East and Africa Enoxaparin Sodium Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Enoxaparin Sodium Historic Market Analysis by Type

  • 4.1 Global Enoxaparin Sodium Sales Market Share by Type (2016-2021)
  • 4.2 Global Enoxaparin Sodium Revenue Market Share by Type (2016-2021)
  • 4.3 Global Enoxaparin Sodium Price by Type (2016-2021)

5 Global Enoxaparin Sodium Historic Market Analysis by Application

  • 5.1 Global Enoxaparin Sodium Sales Market Share by Application (2016-2021)
  • 5.2 Global Enoxaparin Sodium Revenue Market Share by Application (2016-2021)
  • 5.3 Global Enoxaparin Sodium Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Sanodz
    • 6.1.1 Sanodz Corporation Information
    • 6.1.2 Sanodz Description and Business Overview
    • 6.1.3 Sanodz Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Sanodz Product Portfolio
    • 6.1.5 Sanodz Recent Developments/Updates
  • 6.2 Themis Medicare Limited
    • 6.2.1 Themis Medicare Limited Corporation Information
    • 6.2.2 Themis Medicare Limited Description and Business Overview
    • 6.2.3 Themis Medicare Limited Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Themis Medicare Limited Product Portfolio
    • 6.2.5 Themis Medicare Limited Recent Developments/Updates
  • 6.3 Shenzhen Techdow Pharmaceutical
    • 6.3.1 Shenzhen Techdow Pharmaceutical Corporation Information
    • 6.3.2 Shenzhen Techdow Pharmaceutical Description and Business Overview
    • 6.3.3 Shenzhen Techdow Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Shenzhen Techdow Pharmaceutical Product Portfolio
    • 6.3.5 Shenzhen Techdow Pharmaceutical Recent Developments/Updates
  • 6.4 Sanofi
    • 6.4.1 Sanofi Corporation Information
    • 6.4.2 Sanofi Description and Business Overview
    • 6.4.3 Sanofi Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Sanofi Product Portfolio
    • 6.4.5 Sanofi Recent Developments/Updates
  • 6.5 Jianyou
    • 6.5.1 Jianyou Corporation Information
    • 6.5.2 Jianyou Description and Business Overview
    • 6.5.3 Jianyou Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Jianyou Product Portfolio
    • 6.5.5 Jianyou Recent Developments/Updates
  • 6.6 Amphastar Pharmaceuticals, Inc.
    • 6.6.1 Amphastar Pharmaceuticals, Inc. Corporation Information
    • 6.6.2 Amphastar Pharmaceuticals, Inc. Description and Business Overview
    • 6.6.3 Amphastar Pharmaceuticals, Inc. Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Amphastar Pharmaceuticals, Inc. Product Portfolio
    • 6.6.5 Amphastar Pharmaceuticals, Inc. Recent Developments/Updates
  • 6.7 Actavis Pharma Company
    • 6.6.1 Actavis Pharma Company Corporation Information
    • 6.6.2 Actavis Pharma Company Description and Business Overview
    • 6.6.3 Actavis Pharma Company Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Actavis Pharma Company Product Portfolio
    • 6.7.5 Actavis Pharma Company Recent Developments/Updates
  • 6.8 Winthrop U.S.
    • 6.8.1 Winthrop U.S. Corporation Information
    • 6.8.2 Winthrop U.S. Description and Business Overview
    • 6.8.3 Winthrop U.S. Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Winthrop U.S. Product Portfolio
    • 6.8.5 Winthrop U.S. Recent Developments/Updates
  • 6.9 Cardinal Health
    • 6.9.1 Cardinal Health Corporation Information
    • 6.9.2 Cardinal Health Description and Business Overview
    • 6.9.3 Cardinal Health Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Cardinal Health Product Portfolio
    • 6.9.5 Cardinal Health Recent Developments/Updates
  • 6.10 NorthStar Rx
    • 6.10.1 NorthStar Rx Corporation Information
    • 6.10.2 NorthStar Rx Description and Business Overview
    • 6.10.3 NorthStar Rx Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 NorthStar Rx Product Portfolio
    • 6.10.5 NorthStar Rx Recent Developments/Updates
  • 6.11 Teva Parenteral Medicines
    • 6.11.1 Teva Parenteral Medicines Corporation Information
    • 6.11.2 Teva Parenteral Medicines Enoxaparin Sodium Description and Business Overview
    • 6.11.3 Teva Parenteral Medicines Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Teva Parenteral Medicines Product Portfolio
    • 6.11.5 Teva Parenteral Medicines Recent Developments/Updates

7 Enoxaparin Sodium Manufacturing Cost Analysis

  • 7.1 Enoxaparin Sodium Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Enoxaparin Sodium
  • 7.4 Enoxaparin Sodium Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Enoxaparin Sodium Distributors List
  • 8.3 Enoxaparin Sodium Customers

9 Enoxaparin Sodium Market Dynamics

  • 9.1 Enoxaparin Sodium Industry Trends
  • 9.2 Enoxaparin Sodium Growth Drivers
  • 9.3 Enoxaparin Sodium Market Challenges
  • 9.4 Enoxaparin Sodium Market Restraints

10 Global Market Forecast

  • 10.1 Enoxaparin Sodium Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Enoxaparin Sodium by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Enoxaparin Sodium by Type (2022-2027)
  • 10.2 Enoxaparin Sodium Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Enoxaparin Sodium by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Enoxaparin Sodium by Application (2022-2027)
  • 10.3 Enoxaparin Sodium Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Enoxaparin Sodium by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Enoxaparin Sodium by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    30 mg/0.3mL
    60 mg/0.6mL
    100 mg/1mL
    120 mg/0.8mL
    150 mg/1mL

    Segment by Application
    Hospital
    Drugs Store

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Sanodz
    Themis Medicare Limited
    Shenzhen Techdow Pharmaceutical
    Sanofi
    Jianyou
    Amphastar Pharmaceuticals, Inc.
    Actavis Pharma Company
    Winthrop U.S.
    Cardinal Health
    NorthStar Rx
    Teva Parenteral Medicines

    Buy now